Filing Details
- Accession Number:
- 0001209191-21-025756
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-06 20:00:35
- Reporting Period:
- 2021-04-01
- Accepted Time:
- 2021-04-06 20:00:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1564824 | Allakos Inc. | ALLK | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1271905 | Md S Henrik Rasmussen | 975 Island Drive, Suite 201 Redwood City CA 94065 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-06 | 10,000 | $111.68 | 101,819 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-06 | 10,000 | $1.16 | 111,819 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-05 | 20,000 | $113.06 | 101,819 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-05 | 20,000 | $1.16 | 121,819 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-01 | 20,000 | $114.40 | 101,819 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-01 | 20,000 | $1.16 | 121,819 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | Disposition | 2021-04-06 | 10,000 | $0.00 | 10,000 | $1.16 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2021-04-05 | 20,000 | $0.00 | 20,000 | $1.16 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2021-04-01 | 20,000 | $0.00 | 20,000 | $1.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 282,000 | 2027-10-02 | No | 4 | M | Direct | |
| 292,000 | 2027-10-02 | No | 4 | M | Direct | |
| 312,000 | 2027-10-02 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. This transaction was executed in multiple trades at prices ranging from $109.00 to $113.03 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
- Includes shares of common stock purchased under the Company's 2018 Employee Stock Purchase Plan.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. This transaction was executed in multiple trades at prices ranging from $111.24 to $115.90 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. This transaction was executed in multiple trades at prices ranging from $112.06 to $116.25 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
- On October 2, 2017, the Reporting Person was granted an option to purchase 392,000 ordinary shares pursuant to the Company's 2018 Equity Incentive Plan. The option vests as to one-fourth of the shares on October 2, 2018, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Billionaire Hedge Funds
